COMMUNIQUÉS West-GlobeNewswire

-
VIFOR PHARMA ANNOUNCES CHANGES IN MANAGEMENT
20/09/2018 -
IntelGenx Signs Letter of Intent with Tilray® to Enter Into a World-Wide Agreement To Produce Cannabis-Infused VersaFilm™ Products
20/09/2018 -
R1 RCM to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
20/09/2018 -
Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD
20/09/2018 -
Precision Optics Corporation Schedules Fiscal Year End Conference Call
19/09/2018 -
Healthcare Special Opportunities Fund Announces September 2018 Quarterly Distribution
19/09/2018 -
Spectrum Health & Human Services Selects Cerner to Support Improved Behavioral Health Care Delivery
19/09/2018 -
Veritas’ Cannevert to Offer Testing Services for Cannabis & Hemp Licensed Producers; Corporate Update
19/09/2018 -
Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018
19/09/2018 -
TESARO Announces Participation at Two Investor Conferences
19/09/2018 -
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
19/09/2018 -
Integra LifeSciences to participate in the Cantor Global Healthcare Conference
19/09/2018 -
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
19/09/2018 -
Oncolytics Biotech® Provides Corporate and Clinical Update
19/09/2018 -
CherryCircle Software Inc. Releases QbDVision™ for Pharmaceutical Process Development and Manufacturing
19/09/2018 -
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
19/09/2018 -
Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
19/09/2018 -
SPINEWAY : Early redemption of 44 ORNANE Notes End of bond financing by ORNANE
19/09/2018 -
SPINEWAY : Remboursement anticipé de 44 ORNANE Fin du financement obligataire par ORNANE
19/09/2018
Pages